Dopaminergic Neurons Transplanted Using Cell‐Instructive Biomaterials Alleviate Parkinsonism in Rodents

Cell replacement therapy (CRT) is a promising treatment for degenerative disorders, such as Parkinson's disease (PD). However, CRT is in general hindered by poor graft survival, limited cell dispersion, modest cell integration, and delayed therapeutic efficacy. These challenges need to be addre...

Full description

Saved in:
Bibliographic Details
Published in:Advanced functional materials 2018-10, Vol.28 (41), p.n/a
Main Authors: Adil, Maroof M., Rao, Antara T., Ramadoss, Gokul N., Chernavsky, Nicole E., Kulkarni, Rishikesh U., Miller, Evan W., Kumar, Sanjay, Schaffer, David V.
Format: Article
Language:English
Subjects:
biomedical applications
Biomedical materials
Disease control
Dispersion
Hyaluronic acid
Hydrogels
Materials science
Neurons
Parkinson's disease
Rodents
Stem cells
Survival
tissue engineering
Transplantation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cell replacement therapy (CRT) is a promising treatment for degenerative disorders, such as Parkinson's disease (PD). However, CRT is in general hindered by poor graft survival, limited cell dispersion, modest cell integration, and delayed therapeutic efficacy. These challenges need to be addressed to enhance the clinical translation of CRT. Here, key bioactive factors that increase the survival and dispersion of human pluripotent stem cell‐derived midbrain dopaminergic (mDA) neurons, the primary type of cells lost in PD, are identified. mDA neurons cotransplanted with survival and dispersion factors within a protective hyaluronic acid hydrogel, optimized for controlled factor release and cell spread, alleviate disease symptoms in PD model rats. Importantly, treatment benefits correlate with increased graft survival, dispersion, and integration. Optimally engineered cell‐instructive transplantation platforms thus offer promise for enhancing CRT in PD and potentially a range of degenerative diseases or trauma. Midbrain dopaminergic neurons derived from human pluripotent stem cells and encapsulated in a hydrogel‐based transplantation platform, which also incorporated factors that are capable of promoting graft survival, dispersion, and integration, enhance therapeutic efficacy upon implantation into a rodent model of Parkinson's disease.
ISSN:1616-301X
1616-3028
DOI:10.1002/adfm.201804144